PEB
PACIFIC EDGE ORD FOR.EXEMPT NZXPacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the stratification and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up in microhematuria patients; Cxbladder Detect, which improve practice workflow and efficiency in urological care; Cxbladder Triage Plus, a non-invasive surveillance alternative that can reduce the burden of repeated cystoscopy in patients; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a recurrent non-muscle invasive bladder cancer. In addition, the company is developing products for bladder, gastric, colorectal and endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
PEB
PEB
PACIFIC EDGE ORD FOR.EXEMPT NZX
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.09% | — |
| 10 July | 0.09% | — |
| 9 July | 0.09% | — |
| 8 July | 0.09% | — |
| 7 July | 0.09% | — |
| 6 July | 0.09% | — |
| 3 July | 0.09% | — |
| 2 July | 0.09% | — |
| 1 July | 0.09% | — |
Pacific Edge Ord For.exempt Nzx (PEB) Short Interest Summary
Pacific Edge Ord For.exempt Nzx (PEB) currently has 0.09% of its shares sold short (1.1 million shares, worth approximately $261K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes PEB the #476 most shorted stock on the ASX most shorted list. Short interest in PEB is up 0.00% over the past week and up 0.00% over the past month. PEB is part of the Health Care sector on the ASX.
Recent PEB Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.09% | 1.1M | $0.24 |
| 10 July 2026 | 0.09% | 1.1M | $0.25 |
| 9 July 2026 | 0.09% | 1.1M | $0.25 |
| 8 July 2026 | 0.09% | 1.1M | $0.23 |
| 7 July 2026 | 0.09% | 1.1M | $0.23 |
| 6 July 2026 | 0.09% | 1.1M | $0.23 |
| 3 July 2026 | 0.09% | 1.1M | $0.23 |
| 2 July 2026 | 0.09% | 1.1M | $0.25 |
| 1 July 2026 | 0.09% | 1.1M | $0.25 |
| 30 June 2026 | 0.09% | 1.1M | $0.25 |
PEB Short Selling — Frequently Asked Questions
What is Pacific Edge Ord For.exempt Nzx (PEB)'s current short interest?
Pacific Edge Ord For.exempt Nzx (PEB) currently has a short interest of 0.09% of total shares outstanding. This means 0.09% of PEB's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is PEB heavily shorted on the ASX?
PEB has a relatively low short interest of 0.09%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for PEB investors?
Short interest in PEB shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.09%, PEB's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this PEB short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for PEB.